Work

Concordance of CSF biomarkers with amyloid PET at baseline in EMERGE/ENGAGE, phase 3 studies of aducanumab in patients with early Alzheimer’s disease

Year: 2022

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1002/alz.069382

Authors: Carrie E. Rubel, Laura Nisenbaum, Tianle Chen, Gersham Dent, Kyle Fraser, Danielle Graham, Katie Harrison, Ping He, Annie M Racine, Raj Rajagovindan, John Beaver, Samantha Budd Haeberlein

Institutions: Alzheimer's Drug Discovery Foundation, Biogen (United States)

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4312086192

FWCI:

Cites:

Cited by:

Related to: 10